These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6893891)

  • 1. Pharmacological properties of a potent neuroleptic drug octoclothepin.
    Metysová J; Metys J; Dlabac A; Kazdová E; Valchár M
    Acta Biol Med Ger; 1980; 39(6):723-40. PubMed ID: 6893891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. IV. Antiadrenergic action and influence on brain monoamines.
    Dlabac A; Metys J; Metysová J
    Act Nerv Super (Praha); 1971; 13(3):188-9. PubMed ID: 5113833
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological properties of the new neuroleptic of the phenothiazine series--dixyrazine].
    Mikhaĭlova TV; Terekhina AI; Gilev AP
    Farmakol Toksikol; 1969; 32(1):28-31. PubMed ID: 4388895
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological study of [2-chloro-11-(2-dimethylaminoethoxy) dibenzo[b,f]thiepine] (zotepine), a new neuroleptic drug.
    Uchida S; Honda F; Otsuka M; Satoh Y; Mori J; Ono T; Hitomi M
    Arzneimittelforschung; 1979; 29(10):1588-94. PubMed ID: 42413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. I. The action on the central nervous system in rodents.
    Metysová J; Metys J
    Act Nerv Super (Praha); 1971; 13(3):185-6. PubMed ID: 5165408
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. II. Influence on behaviour in rats.
    Kazdová E; Metysová J; Dlabac A
    Act Nerv Super (Praha); 1971; 13(3):186-7. PubMed ID: 5113831
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological comparison of a new neuroleptic drug methiothepin with octoclothepin and chlorpromazine.
    Metysová J
    Act Nerv Super (Praha); 1968 Oct; 10(3):332-3. PubMed ID: 5702554
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastrointestinal prokinetic and antiemetic effects of a new substituted pyrimidinO 6553 (2-methylamino-4-N-methylpiperazino-5-thiomethyl-6-chloropyrimidine hydrochloride).
    Loiseau G; Millischer R; Donadieu AM; Marquet JP
    Arzneimittelforschung; 1977; 27(3):606-11. PubMed ID: 577427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of octoclothepin and perphenazine on behaviour in rats with different exploration and defecation rates.
    Kazdová E; Dlabac A; Benesová O
    Act Nerv Super (Praha); 1974 Mar; 16(1):73-5. PubMed ID: 4454952
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Stereospecificity of neuroleptic effects in the 10-piperazino-10, 11-dihydrodibenzo (b, f) thiepin series.
    Metysová J; Protiva M
    Act Nerv Super (Praha); 1975; 17(4):218-9. PubMed ID: 1221761
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the behavioural effect of octoclothepin and perphenazine in rats.
    Kazdová E
    Act Nerv Super (Praha); 1970; 12(3):266. PubMed ID: 5457454
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study on the pharmacological properties of the neuroleptics octoclothepine and chlorpromazine.
    Metysová J; Metys J
    Act Nerv Super (Praha); 1967 Nov; 9(4):424-5. PubMed ID: 5612966
    [No Abstract]   [Full Text] [Related]  

  • 13. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD; Harting J; Minck KO
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicological and pharmacological effects of D-arginine.
    Navarro E; Alonso SJ; Martín FA; Castellano MA
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):149-54. PubMed ID: 16128908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological effects of deltamethrin on the central nervous system.
    Pham Huu Chanh ; Navarro-Delmasure C; Pham Huu Chanh ; Cheav SL; Ziade F; Samaha F
    Arzneimittelforschung; 1984; 34(2):175-81. PubMed ID: 6539110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for quantitative estimation of the central depressant effect of neuroleptics on the spontaneous motility of rats.
    Sandberg F
    Exp Med Surg; 1967; 25(1):236-43. PubMed ID: 5618936
    [No Abstract]   [Full Text] [Related]  

  • 20. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.